Millennium Management
RPTX

Millennium Management’s Repare Therapeutics RPTX Stock Holding History

Millennium Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-72,500
Closed -$1.07M – 6784
2022
Q4 		$1.07M Buy
+72,500
New +$1.08M ﹤0.01% 4102
2022
Q3 		– Sell
-40,000
Closed -$560K – 7426
2022
Q2 		$560K Buy
+40,000
New +$471K ﹤0.01% 4862

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

Millennium Management's RPTX Position: Q3 2025 in Review

Millennium Management sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 407,858 shares — an estimated $567K sold.

Millennium Management first reported a position in RPTX in Q2 2020 and held it in 20 quarters. The position peaked at $8.9M in Q4 2022. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

  • Millennium Management reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 407,858 Repare Therapeutics shares in Q3 2025, an estimated $567K.
  • Millennium Management first reported a position in Repare Therapeutics in Q2 2020 and held it in 20 quarters.
  • Millennium Management's Repare Therapeutics position peaked at $8.9M in Q4 2022.
  • 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.